RNA Research Solutions
-
R1044 EZ Cap™ CBEmax mRNA (m1Ψ)Summary: Cytosine Base Editor (CBE) mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1107 Enhanced EZ Cap™ Firefly Luciferase mRNA (m1Ψ)1 CitationSummary: Sequence-optimized firefly luciferase mRNA (Fluc mRNA) with Cap 1 structure, modified by m1Ψ, significantly enhances the protein expression efficiency -
R1101 EZ Cap™ BFP mRNA (m1Ψ)Summary: Blue fluorescent protein (BFP) mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1127 EZ Cap™ SaCas9 mRNASummary: SaCas9 mRNA with Cap 1 structure, providing higher transcription efficiency -
B7977 5-Methyl-UTPSummary: Modified nucleoside triphosphate with methylation at the 5-carbon position of uracil, affecting RNA structure and function. -
B7991 N1-Methylguanosine-5'-TriphosphateSummary: Modified nucleoside triphosphate with methylation at the N1 position of guanine, affecting RNA translation and stability. -
B7992 2'-O-Methyl-2-Amino-ATPSummary: Modified nucleoside triphosphate with methylation at the 2'-hydroxyl group and an amino substitution at the 2-position of the adenine ring, used for RNA stability studies. -
B7993 2'-O-Methylpseudo-UTPSummary: Modified nucleoside triphosphate with 2'-hydroxyl methylation, enhancing RNA stability and reducing degradation. -
B7994 N1-Methyl-ATPSummary: Modified nucleoside triphosphate with methylation at the N1 position of adenine, affecting nucleic acid structure and function. -
B8044 Aminoallyl-CTP

